What is it about?
In this paper, we reviewed some biomarkers for different types of dementia (Alzheimer's, Parkinson's, Frontotemporal, Lewy Body and vascular dementia) focusing on those that can be measured in blood. Despite all the advances in modern medicine, in most cases, different dementia types can only be diagnosed through neuropsychological studies, neuroimaging and clinical data of patients. However, nowadays, new blood-based biomarkers for dementia are arising.
Photo by Hush Naidoo Jade Photography on Unsplash
Why is it important?
Developing accurate, easy-to-use and inexpensive blood-based biomarkers to diagnose dementia is a long-standing aspiration for researchers and the medical community. This review offers an update on the current landscape of blood-based dementia biomarkers.
Read the Original
This page is a summary of: Potential Protein Blood-Based Biomarkers in Different Types of Dementia: A Therapeutic Overview, Current Pharmaceutical Design, April 2022, Bentham Science Publishers, DOI: 10.2174/1381612828666220408124809.
You can read the full text:
The following have contributed to this page